Trial Profile
Phase I trial of Cetuximab combined with S-1 and irrinotecan in advanced colorectal cancer
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Cetuximab (Primary) ; Gimeracil/oteracil/tegafur (Primary) ; Irinotecan (Primary)
- Indications Colorectal cancer
- Focus Adverse reactions
- 10 May 2012 New trial record